Lung Cancer Archives - Medical Conferences

Selective RET inhibitor selpercatinib doubles progression-free survival in RET-mutated NSCLC

Presented By

Prof. Herbert Ho Fung Loong, Chinese University of Hong Kong, China

Trial

Phase 3, LIBRETTO-431

Conference

ESMO 2023

Type

Peer-reviewed article

19 December 2023 09:54

The importance of detecting early NSCLC

Expert

Prof. Witold Rzyman, Medical University of Gdańsk, Poland

Conference

ESMO 2023

20 November 2023 15:34

Real-world data support new SOC in patients with SCLC

Expert

Prof. Nicolas Girard, Institut Curie, Paris, France

Trial

IFCT 1905-CLINATEZO

10 October 2023 17:24

Confirmatory mediastinoscopy not needed in resectable NSCLC

Presented By

Prof. Jouke Annema, Amsterdam UMC, the Netherlands

Trial

MEDIASTrial

Conference

ERS 2022

Type

Peer-reviewed article

30 October 2022 21:30

First DLL3-targeted therapy shows promise in SCLC

Presented By

Prof. Hossein Borghaei, Fox Chase Cancer Center, PA, USA

Trial

Phase 1

Conference

WCLC 2022

Type

News article

23 August 2022 10:43

KEYNOTE-604: Very durable responses on pembrolizumab plus EP in SCLC

Presented By

Dr Charles Rudin, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, KEYNOTE-604

Conference

WCLC 2022

Type

News article

23 August 2022 10:41

Talazoparib plus temozolomide appears efficacious in ES-SCLC

Presented By

Dr Jonathan Goldman, David Geffen School of Medicine at UCLA, CA, USA

Trial

Phase 2

Conference

WCLC 2022

Type

News article

23 August 2022 10:37

Pembrolizumab plus lenvatinib performs well in MPM

Presented By

Dr Li-Anne Douma, Netherlands Cancer Institute - Antoni van Leeuwenhoek, the Netherlands

Trial

Phase 2, PEMMELA

Conference

WCLC 2022

Type

News article

23 August 2022 10:34

Early detection strategies in younger patients with lung cancer are urgently needed

Presented By

Dr Alexandra Potter, Massachusetts General Hospital, MA, USA

Conference

WCLC 2022

Type

News article

23 August 2022 10:27

Intensive co-located smoking cessation programme highly effective during lung screening

Presented By

Prof. Rachael Murray, University of Nottingham, UK

Trial

YESS

Conference

WCLC 2022

Type

News article

23 August 2022 10:24

Do we underestimate the effect of air pollution on lung cancer incidence?

Presented By

Dr Renelle Myers, University of British Columbia, Canada

Conference

WCLC 2022

Type

News article

23 August 2022 10:21

Interventions needed to address sexual health in lung cancer

Presented By

Dr Narjust Florez, Dana Farber Cancer Institute, MA, USA

Trial

SHAWL

Conference

WCLC 2022

Type

News article

23 August 2022 10:18

Additional tiragolumab does not help patients with untreated small cell lung cancer

Presented By

Dr Charles Rudin, Memorial Sloan Kettering Cancer Center, NY, USA

Trial

Phase 3, SKYSCRAPER-02

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 12:42

Success for serplulimab plus chemotherapy in small cell lung cancer

Presented By

Prof. Ying Cheng, Jilin Cancer Hospital, China

Trial

Phase 3, ASTRUM-005

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 12:38

Adagrasib safe and clinically active in non-small cell lung cancer

Presented By

Dr Alexander Spira, Virginia Cancer Specialists Research Institute, VA, USA

Trial

Phase 2, KRYSTAL-1

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 12:33

Long-term benefits of combined immunotherapy over chemotherapy in non-small cell lung cancer

Presented By

Prof. Julie Brahmer, Sidney Kimmel Comprehensive Cancer Center, Australia

Trial

Phase 3, CheckMate 227

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 12:29

Effect of KRAS mutations and PD-L1 expression on therapy response in non-small cell lung cancer

Presented By

Dr Oladimeji Akinboro, US Food and Drug Administration, MD, USA

Conference

ASCO 2022

Type

Peer-reviewed article

5 August 2022 12:26

Total metabolic tumour volume: a new potential prognostic factor in SCLC

Presented By

Dr Elisa Andrini, Sant'Orsola-Malpighi University Hospital, Italy

Conference

ELCC 2022

Type

Peer-reviewed article

25 May 2022 12:34

Radiation dose on oesophagus predicts OS in SCLC patients treated with chemoradiotherapy

Presented By

Dr Bilal Tahir, University of Sheffield, United Kingdom

Conference

ELCC 2022

Type

Peer-reviewed article

25 May 2022 12:34

Characteristics of long-term survivors in the CASPIAN trial

Presented By

Dr Niels Reinmuth, Asklepios Lung Clinic, Germany

Trial

Phase 3, CASPIAN

Conference

ELCC 2022

Type

Peer-reviewed article

25 May 2022 12:34

Outcomes of real-world CANTABRICO trial match results from CASPIAN

Presented By

Dr Dolores Isla, Hospital Clinico Universitario Lozano Blesa, Spain

Trial

CANTABRICO

Conference

ELCC 2022

Type

Peer-reviewed article

25 May 2022 12:33

ELCC 2022 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

ELCC 2022

19 April 2022 10:43

Three-year OS follow-up from CASPIAN trial

Presented By

Dr Luis Paz-Ares, Hospital Universitario 12 de Octubre, Spain

Trial

Phase 3, CASPIAN

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:32

ESMO 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Trial

DESTINY-Breast03, MONALEESA-2, KEYNOTE-716, CASPIAN, CheckMate-649, Impower010

Conference

ESMO 2021

4 October 2021 09:27

WCLC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Conference

WCLC 2021

29 September 2021 11:21

Interim results of nivolumab + rucaparib in SCLC

Presented By

Dr Aman Chauhan, University of Kentucky, KY, USA

Conference

WCLC 2021

Type

News article

21 September 2021 13:24

Neoadjuvant nivolumab plus chemotherapy improves surgical outcomes in NSCLC

Presented By

Dr Jonathan Spicer, McGill University, Canada

Trial

Phase 3, CheckMate 816

Conference

ASCO 2021

Type

Peer-reviewed article

12 August 2021 23:59

Immune-related adverse events are associated with efficacy of atezolizumab in patients with advanced NSCLC

Presented By

Dr Mark Socinski, AdventHealth Cancer Institute, FL, USA

Trial

Phase 3, IMpower130, IMpower132, IMpower150

Conference

ASCO 2021

Type

Peer-reviewed article

12 August 2021 22:02

Sustained efficacy of nivolumab/ipilimumab plus 2 cycles of chemotherapy in NSCLC

Presented By

Prof. Martin Reck, Lung Clinic Grosshansdorf, Germany

Trial

Phase 3, CheckMate 9LA

Conference

ASCO 2021

Type

Peer-reviewed article

12 August 2021 22:00

Patritumab deruxtecan (HER3-DXd) in EGFR TKI-resistant NSCLC

Presented By

Dr Jänne Pasi, Dana Farber Cancer Institute, MA, USA

Trial

Phase 1

Conference

ASCO 2021

Type

Peer-reviewed article

12 August 2021 20:08

Chemoimmunotherapy is effective in a subset of small cell lung cancer patients

Presented By

Prof. Taofeek Owonikoko, Emory University School of Medicine

Trial

KEYNOTE-604, ECOG-ACRIN EA5161

Journal

Physician’s Weekly

Conference

ASCO20 Virtual Meeting

15 April 2021 16:03

ES-SCLC: CASPIAN trial perspectives from Prof. Jonathan Goldman

Presented By

Prof. Jonathan Goldman, Prof. Luis Paz-Ares

Trial

Phase 3, CASPIAN

Journal

Physician Weekly

Conference

ASCO Annual Meeting 2020

13 April 2021 16:27

Consolidation ipilimumab and nivolumab in limited stage SCLC

Conference

ESMO 2020

Type

Peer-reviewed article

25 November 2020 14:56

Lung cancer screening: Most patients not eligible 1-2 years prior to diagnosis

Presented By

Dr Kiran Desai, Barking, Havering and Redbridge University Hospitals, UK

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 19:43

Biomarkers: a novel tool to improve lung nodule classification

Presented By

Dr Michael Pritchett

Trial

PANOPTIC, ORACLE

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 19:40

Distinct changes in lung microbiome precede clinical diagnosis of lung cancer

Presented By

Ms Erin Marshall, University of British Columbia, Canada

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 19:30

Social smoking: Do not underestimate the risks

Presented By

Dr Pallavi Balte, Columbia University, USA

Conference

ERS 2020

Type

Peer-reviewed article

29 October 2020 19:04

Higher thrombotic risk in NSCLC patient with ALK rearrangement

Presented By

Dr Hanny Al-Samkari, Massachusetts General Hospital, USA

Conference

ISTH 2020

Type

Peer-reviewed article

8 September 2020 14:41

Mixed data: AMG 510 in tumours with KRASG12C

Presented By

Prof. Ramaswamy Govindan, Washington University, St Louis, USA

Conference

ESMO 2019

Type

Peer-reviewed article

26 November 2019 23:30

New technologies in lung cancer detection

Conference

WCLC 2019

Type

Peer-reviewed article

8 November 2019 22:50

Neoadjuvant nivolumab/ipilimumab shows promise in resectable NSCLC

Presented By

Dr Tina Cascone, University of Texas MD Anderson Cancer Centre, USA

Trial

NEOSTAR

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 23:59

Overcoming the challenges of immunotherapy in non–small cell lung cancer

Presented By

Dr Sarah B. Goldberg, Dr Melissa Lynne Johnson, Dr Alexander Chi

Trial

PACIFIC, KEYNOTE-024, KEYNOTE-189

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 22:04

Repotrectinib shows encouraging safety, efficacy for patients with ROS1+ NSCLC

Presented By

Dr Byoung Chul Cho, Yonsei Cancer Centre, South Korea

Trial

TRIDENT-1

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 21:15

Pembrolizumab monotherapy leads to 5-year survival in some patients with NSCLC

Presented By

Dr Edward B. Garon, David Geffen School of Medicine, USA

Trial

Phase 1, KEYNOTE-001

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 20:17

Novel RET inhibitor BLU-667 offers promise for RET+ advanced NSCLC

Presented By

Dr Justin F. Gainor, Massachusetts General Hospital, USA

Trial

Phase 1, ARROW

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 19:23

Lurbinectedin shows promise as second-line therapy for SCLC

Presented By

Dr Luis G. Paz-Ares, Hospital Universitario 12 de Octubre, Spain

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 18:27

Early results from TAK-788 in NSCLC with EGFR exon 20 insertions

Presented By

Dr Gregory Riely, Memorial Sloan Kettering Cancer Centre, USA

Conference

ASCO 2019

Type

Peer-reviewed article

15 July 2019 13:31

Experiences from Germany

Presented By

Prof. Jürgen Wolf, University Hospital of Cologne, Germany

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 23:31

Post-discontinuation immunotherapy in PACIFIC

Presented By

Dr Phillip Dennis, Dr Marina Garassino

Trial

Phase 3, PACIFIC

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 23:23

Molecular characteristics of SCLC

Presented By

Dr Simon Ekman, Karolinska University Hospital, Sweden

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 23:13

I-O monotherapy

Presented By

Prof. Martin Reck, Airway Research Center North, Grosshansdorf, Germany

Trial

CheckMate 026, Keynote-024, Checkmate 227, MYSTIC, B-F1RST

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 23:13

Incidence and local treatment

Presented By

Prof. Michael Weller, University Hospital Zurich, Switzerland

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 23:03

Tumour, node, and metastasis (TNM) staging system

Presented By

Dr Walter Weder, Dr Ramón Rami-Porta

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 23:02

Combo I-O plus chemotherapy

Presented By

Dr Luis Paz-Ares, Complutense University of Madrid, Spain

Trial

Keynote-189, Impower-132

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 22:15

Brain irradiation as treatment option

Presented By

Prof. Corinne Faivre-Finn, The Christie NHS Foundation Trust and University of Manchester, UK

Trial

Phase 3, QUARTZ

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 22:07

Other I-O combinations

Presented By

Prof. Solange Peters, Lausanne University Hospital and Ludwig Institute, Switzerland

Trial

IMpower 150

Conference

ELCC 2019

25 June 2019 21:17

Experiences from France

Presented By

Dr Benjamin Besse, Institut Gustave Roussy, France

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 20:57

Post-study immunotherapy in MYSTIC

Presented By

Dr Niels Reinmuth, Asklepios Lung Clinic, Munich-Gauting, Germany

Trial

Phase 3, MYSTIC

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 13:26

Predictive diagnostics for I-O

Presented By

Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain

Trial

Phase 3, BFAST

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 13:19

Electromagnetic navigation bronchoscopy

Presented By

Dr Kelvin Lau, St Bartholomew’s Hospital, London, United Kingdom

Trial

NAVIGATE

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 13:10

Genomic and immune profiling

Presented By

Dr Ke-Zhong Chen, Peking University People’s Hospital, Beijing, China

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 13:08

Treatment options in early NSCLC

Presented By

Dr Walter Weder, Dr Raffaele Califano

Trial

CALGB 9633

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 13:04

Immunotherapy in SCLC: trial data

Presented By

Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain

Trial

CA184-156, CheckMate-451, CASPIAN, Keynote-604, Checkmate 032

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 08:15

Systemic therapy of brain metastases

Presented By

Dr Natasha Leighl, Dr Edrune Arriola Aperribay

Trial

Phase 3, FLAURA, ALEX, ALTA-1L, AURA3

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 08:09

How can societies help to implement personalised treatment?

Presented By

Prof. Rolf Stahel, Prof. Giorgio Scagliotti

Conference

ELCC 2019

Type

Peer-reviewed article

25 June 2019 07:59

Small-cell lung cancer circulating tumour cell derived explants

Conference

WCLC 2018

Type

Peer-reviewed article

21 November 2018 23:00

Spread through air spaces is prognostic in lung neuroendocrine tumours

Conference

WCLC 2018

Type

Peer-reviewed article

21 November 2018 22:04